trending Market Intelligence /marketintelligence/en/news-insights/trending/Oa3WCGJT9OC6mocZkvlMaw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Morgan Stanley downgrades CNO Financial as weak sales continue

Infrastructure Issues: Tools to Dig Deep on Potential Risks

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report


Fintech Funding Flows To Insurtech In February

Morgan Stanley downgrades CNO Financial as weak sales continue

Morgan Stanley's Nigel Dally downgraded CNO Financial Group Inc.'s stock to "underweight" from "equal-weight."

The rating reflects the company sales' "slow but steady deterioration" and its lowered expectations regarding return-on-equity improvement. Dally also calculated the stock's 12-month price target at $21. The stock had closed at $23.14 on Aug. 11, making the downgrade in part due to valuation.